Login / Signup

Estimating the potential impact of implementing pre-emptive pharmacogenetic testing in primary care across the UK.

Essra YoussefCharlotte L KirkdaleDavid John WrightHenk-Jan GuchelaarTracey Thornley
Published in: British journal of clinical pharmacology (2021)
Actionable drug-gene interactions frequently occur in UK primary care, with a large opportunity to optimise prescribing.
Keyphrases
  • primary care
  • cross sectional
  • general practice
  • copy number
  • genome wide
  • quality improvement
  • emergency department
  • adverse drug
  • human health
  • risk assessment
  • climate change
  • genome wide analysis